166 related articles for article (PubMed ID: 6247661)
41. Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum.
Mukai J; Asai T; Naka M; Tanaka T
Br J Pharmacol; 1994 Feb; 111(2):389-90. PubMed ID: 8004382
[TBL] [Abstract][Full Text] [Related]
42. Selective inhibition by NPT 15392 of lymphocyte cyclic GMP phosphodiesterase.
Coffey RG; Hartley L; Polson JB; Krzanowski JJ; Hadden JW
Biochem Pharmacol; 1984 Nov; 33(21):3411-7. PubMed ID: 6093811
[TBL] [Abstract][Full Text] [Related]
43. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
Mohindru A; Chenet A; Rhoads AR
Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
[No Abstract] [Full Text] [Related]
44. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
46. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
47. Cyclic nucleotide-phosphodiesterase in the uninvolved and involved skin of psoriasis.
Iizuka H; Adachi K; Halprin KM; Levine V
J Invest Dermatol; 1978 May; 70(5):246-9. PubMed ID: 205615
[TBL] [Abstract][Full Text] [Related]
48. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates.
Alvarez R; Daniels DV
Anal Biochem; 1992 May; 203(1):76-82. PubMed ID: 1326236
[TBL] [Abstract][Full Text] [Related]
49. Subcellular localization of muscarinic effects on enzymes of cyclic nucleotide metabolism in cultured corneal epithelial cells of the rabbit.
Colley AM; Cavanagh HD; Law ML
Metab Pediatr Syst Ophthalmol (1985); 1987; 10(2):36-8. PubMed ID: 2908207
[TBL] [Abstract][Full Text] [Related]
50. Cyclic nucleotide phosphodiesterase from rat small intestine: the separation of the cyclic GMP and cyclic AMP phosphodiesterases.
Yamamoto S
Bull Osaka Med Sch; 1977 Oct; 23(2):92-106. PubMed ID: 210871
[No Abstract] [Full Text] [Related]
51. Glucose exerts opposite effects on mRNA versus protein and activity levels of Pde1, the low-affinity cAMP phosphodiesterase from budding yeast, Saccharomyces cerevisiae.
Wera S; Ma P; Thevelein JM
FEBS Lett; 1997 Dec; 420(2-3):147-50. PubMed ID: 9459299
[TBL] [Abstract][Full Text] [Related]
52. Properties of adenylate cyclase and cyclic nucleotide phosphodiesterase in hamster isolated capillary preparations.
Nemecek GM
Biochim Biophys Acta; 1980 Mar; 628(2):125-35. PubMed ID: 6244001
[TBL] [Abstract][Full Text] [Related]
53. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
Guan WR; Cheung WY
Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844
[No Abstract] [Full Text] [Related]
54. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
55. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
Azhar S; Menon KM
Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
[TBL] [Abstract][Full Text] [Related]
56. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
57. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
Hidaka H; Yamaki T; Ochiai Y; Asano T; Yamabe H
Biochim Biophys Acta; 1977 Oct; 484(2):398-407. PubMed ID: 199262
[TBL] [Abstract][Full Text] [Related]
58. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
Methven P; Lemon M; Bhoola K
Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
[TBL] [Abstract][Full Text] [Related]
59. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
Onali P; Schwartz JP; Hanbauer I; Costa E
Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
[TBL] [Abstract][Full Text] [Related]
60. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
Erneux C; Miot F
Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]